Recurrent Tumor: Clinical Trials

7 trials for Recurrent Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 3 completed. 3 Not applicable, 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable3Recruiting 3
Phase 13Completed 2, Recruiting 1
Phase 22Completed 1, Recruiting 1

Follow Recurrent Tumor: new trials by email Literature Review of Recurrent Tumor trials Research Report on Recurrent Tumor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
LMP744, Conventional Surgery or Biopsy - Recurrent Glioblastoma, Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
Phase 1 / Phase 2RecruitingNational Institute of Neurological Disorders and Stroke (NINDS)402026-07-152026-10-16
Donafenib as Adjuvant Therapy Following Ablation for Recurrent HCC
Thermal ablation, Donafenib - Hepatocellular Carcinoma, Microwave Ablation
Not applicableRecruitingSun Yat-sen University1082024-10-012024-12-03
Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma
Microwave ablation, Lenvatinib - Hepatocellular Carcinoma, Microwave Ablation
Not applicableRecruitingSun Yat-sen University2742022-07-012023-11-07
REMASTer: REcurrent Brain Metastases After SRS Trial
Radiation Therapy, Steroid Therapy, Laser Interstitial Thermal Therapy - Brain Metastases, Radiation Necrosis
Not applicableRecruitingMonteris Medical2612022-05-102026-10-20
A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors
Ramucirumab - Pediatric Solid Tumor, Refractory Tumor
Phase 1CompletedEli Lilly and Company292015-12-112021-08-17
Virus DNX2401 and Temozolomide in Recurrent Glioblastoma
DNX2401 and Temozolomide - Glioblastoma Multiforme, Recurrent Tumor
Phase 1CompletedClinica Universidad de Navarra, Universidad de Navarra312013-09-012017-10-24
A Prospective Single Arm Study of Intraoperative Radiotherapy for Locally Advanced or Recurrent Rectal Cancer
intraoperative radiotherapy - Malignant Rectal Neoplasm, Recurrent Tumor
Phase 2CompletedPeter MacCallum Cancer Centre, Australia322004-07-012025-05-31

Narrower conditions

Recurrence (7)  ·  Brain Neoplasms (2)  ·  Carcinoma, Hepatocellular (2)  ·  Central Nervous System Neoplasms (2)  ·  Glioblastoma (2)  ·  Neoplasms (2)  ·  Glioma (1)  ·  Liver Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Rectal Neoplasms (1)

Broader conditions

Disease Attributes (7)  ·  Pathologic Processes (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Neoplasms by Site (6)  ·  Neoplasms (5)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Digestive System Diseases (3)  ·  Digestive System Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Nervous System Diseases (3)  ·  Nervous System Neoplasms (3)  ·  Adenocarcinoma (2)  ·  Astrocytoma (2)  ·  Brain Diseases (2)  ·  Carcinoma (2)

Interventions

Biopsy (1)  ·  Radiotherapy (1)  ·  Ramucirumab (1)  ·  Temozolomide (1)  ·  Transurethral Resection of Prostate (1)  ·  donafenib (1)  ·  lenvatinib (1)

Sponsors

Sun Yat-sen University (2)  ·  Clinica Universidad de Navarra, Universidad de Navarra (1)  ·  Eli Lilly and Company (1)  ·  Monteris Medical (1)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  Peter MacCallum Cancer Centre, Australia (1)

Countries

United States (3)  ·  China (2)  ·  Australia (1)  ·  Spain (1)

Top investigators

Feng Duan, Professor (1)  ·  Peter Fecci, MD (1)  ·  Sadhana Jackson, M.D. (1)  ·  Sam Ngan (1)  ·  Sonia Tejada, MD, PhD (1)  ·  Xianhai Mao, Professor (1)